Prolor Biotech Falls to Three-Week Low as Quarterly Loss Widens

Prolor Biotech Inc. declined to the lowest level in almost three weeks after the developer of therapeutic proteins said its first-quarter loss widened.

The shares dropped 2.6 percent to 19.90 shekels at 10:42 a.m. in Tel Aviv, the lowest intraday level since April 16, giving the company a market value of 1.09 billion shekels ($287 million). The TA-25 index declined 1.5 percent today.

Prolor’s loss widened to $4.99 million from $3.46 million in the same period last year.

Before it's here, it's on the Bloomberg Terminal. LEARN MORE